Related topics: cancer cells · cancer · pancreas · cancer research · patients

Oxygen deficiency rewires mitochondria

Mitochondria burn oxygen and provide energy for the body. Cells lacking oxygen or nutrients have to change their energy supply quickly in order to keep growing. Scientists from the Max Planck Institute for Biology of Ageing ...

Cleaning up hydrogen peroxide production

The most common process for making hydrogen peroxide begins with a highly toxic, flammable working solution that is combined with hydrogen, filtered, combined with oxygen, mixed in water, and then concentrated to extremely ...

New nanomedicine slips through the cracks

In a recent study in mice, researchers found a way to deliver specific drugs to parts of the body that are exceptionally difficult to access. Their Y-shaped block catiomer (YBC) binds with certain therapeutic materials forming ...

New blood test rapidly detects signs of pancreatic cancer

Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. But a new diagnostic test ...

A new methodology quickly reveals metabolic fluxes in cells

Although photographs of the underground stations in Barcelona would reveal the number of people waiting, when rush hour takes place, and offer clues about why some stations are busier than others, they can't reveal whether ...

Data guru Hans Rosling dies at 68

Data guru Hans Rosling, a Swedish public health expert famous for combating scientific ignorance with catchy YouTube videos in his mission to promote a "fact-based world", has died at the age of 68, his foundation announced.

NASA climate scientist and astronaut Sellers dies at 61

Piers Sellers, a climate scientist and former astronaut who gained fame late in life for his eloquent commentary about the earth's fragility and his own cancer diagnosis, has died. He was 61.

page 1 from 5

Pancreatic cancer

Pancreatic cancer is a malignant neoplasm of the pancreas. Each year in the United States, about 42,470 individuals are diagnosed with this condition and 35,240 die from the disease. The prognosis is generally poor; less than 5 percent of those diagnosed are still alive five years after diagnosis. Complete remission is still extremely rare. About 95% of exocrine pancreatic cancers are adenocarcinomas (M8140/3). The remaining 5% include adenosquamous carcinomas, squamous cell carcinomas, and giant cell carcinomas. Exocrine pancreatic cancers are far more common than endocrine pancreatic cancers (islet cell carcinomas), which make up about 1% of total cases.

This text uses material from Wikipedia, licensed under CC BY-SA